Amalgamated Bank’s Denali Therapeutics DNLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $60K | Hold |
4,305
| – | – | ﹤0.01% | 1791 |
|
|
2025
Q1 | $59K | Buy |
4,305
+113
| +3% | +$1.55K | ﹤0.01% | 1766 |
|
|
2024
Q4 | $85K | Hold |
4,192
| – | – | ﹤0.01% | 1736 |
|
|
2024
Q3 | $122K | Hold |
4,192
| – | – | ﹤0.01% | 1673 |
|
|
2024
Q2 | $97K | Buy |
4,192
+168
| +4% | +$3.89K | ﹤0.01% | 1719 |
|
|
2024
Q1 | $83K | Sell |
4,024
-13,033
| -76% | -$269K | ﹤0.01% | 1757 |
|
|
2023
Q4 | $366K | Sell |
17,057
-1,198
| -7% | -$25.7K | ﹤0.01% | 1562 |
|
|
2023
Q3 | $377K | Buy |
18,255
+679
| +4% | +$14K | ﹤0.01% | 1545 |
|
|
2023
Q2 | $519K | Buy |
17,576
+2,196
| +14% | +$64.8K | ﹤0.01% | 1419 |
|
|
2023
Q1 | $354K | Sell |
15,380
-2,579
| -14% | -$59.4K | ﹤0.01% | 1571 |
|
|
2022
Q4 | $499K | Buy |
17,959
+2,017
| +13% | +$56K | ﹤0.01% | 1465 |
|
|
2022
Q3 | $489K | Buy |
15,942
+380
| +2% | +$11.7K | ﹤0.01% | 1445 |
|
|
2022
Q2 | $458K | Buy |
15,562
+669
| +4% | +$19.7K | ﹤0.01% | 1504 |
|
|
2022
Q1 | $479K | Sell |
14,893
-1,119
| -7% | -$36K | ﹤0.01% | 1561 |
|
|
2021
Q4 | $714K | Sell |
16,012
-172
| -1% | -$7.67K | 0.01% | 1400 |
|
|
2021
Q3 | $816K | Sell |
16,184
-997
| -6% | -$50.3K | 0.01% | 1348 |
|
|
2021
Q2 | $1.35M | Buy |
17,181
+8,228
| +92% | +$646K | 0.01% | 1139 |
|
|
2021
Q1 | $511K | Sell |
8,953
-875
| -9% | -$49.9K | 0.02% | 965 |
|
|
2020
Q4 | $823K | Buy |
9,828
+49
| +0.5% | +$4.1K | 0.03% | 667 |
|
|
2020
Q3 | $350K | Sell |
9,779
-285
| -3% | -$10.2K | 0.02% | 1032 |
|
|
2020
Q2 | $243K | Buy |
+10,064
| New | +$243K | 0.01% | 1218 |
|